Scholars@Duke publication: Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients.

Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients.

Publication , Conference

Davis, AA; Bucheit, LA; Zhang, N; Pretz, C; Strickler, JH; Chachoua, A; Wise, DR; Wong, K-K; Aviki, EM; Zhang, T; Qin, Q; Clemens, KM

Published in: JOURNAL OF CLINICAL ONCOLOGY

2024

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

2024

APA

Chicago

ICMJE

MLA

NLM

Davis, A. A., Bucheit, L. A., Zhang, N., Pretz, C., Strickler, J. H., Chachoua, A., … Clemens, K. M. (2024). Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Davis, Andrew A., Leslie A. Bucheit, Nicole Zhang, Christopher Pretz, John H. Strickler, Abraham Chachoua, David R. Wise, et al. “Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Davis AA, Bucheit LA, Zhang N, Pretz C, Strickler JH, Chachoua A, et al. Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Davis AA, Bucheit LA, Zhang N, Pretz C, Strickler JH, Chachoua A, Wise DR, Wong K-K, Aviki EM, Zhang T, Qin Q, Clemens KM. Utilization of circulating tumor DNA (ctDNA) testing by race and ethnicity in more than 135,000 patients. JOURNAL OF CLINICAL ONCOLOGY. 2024.

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

2024